These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 26134388)

  • 1. Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women.
    Brahe LK; Le Chatelier E; Prifti E; Pons N; Kennedy S; Blædel T; Håkansson J; Dalsgaard TK; Hansen T; Pedersen O; Astrup A; Ehrlich SD; Larsen LH
    Br J Nutr; 2015 Aug; 114(3):406-17. PubMed ID: 26134388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
    J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
    Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
    Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
    Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice.
    Bagarolli RA; Tobar N; Oliveira AG; Araújo TG; Carvalho BM; Rocha GZ; Vecina JF; Calisto K; Guadagnini D; Prada PO; Santos A; Saad STO; Saad MJA
    J Nutr Biochem; 2017 Dec; 50():16-25. PubMed ID: 28968517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study.
    Hutchins AM; Brown BD; Cunnane SC; Domitrovich SG; Adams ER; Bobowiec CE
    Nutr Res; 2013 May; 33(5):367-75. PubMed ID: 23684438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial.
    Mokkala K; Paulin N; Houttu N; Koivuniemi E; Pellonperä O; Khan S; Pietilä S; Tertti K; Elo LL; Laitinen K
    Gut; 2021 Feb; 70(2):309-318. PubMed ID: 32839200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplementation with flaxseed mucilage alone or in combination with calcium in dogs: effects on apparent digestibility of fat and energy and fecal characteristics.
    Nybroe S; Astrup A; Bjørnvad CR
    Int J Obes (Lond); 2016 Dec; 40(12):1884-1890. PubMed ID: 27528249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.
    Xiao S; Fei N; Pang X; Shen J; Wang L; Zhang B; Zhang M; Zhang X; Zhang C; Li M; Sun L; Xue Z; Wang J; Feng J; Yan F; Zhao N; Liu J; Long W; Zhao L
    FEMS Microbiol Ecol; 2014 Feb; 87(2):357-67. PubMed ID: 24117923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population.
    Haro C; Montes-Borrego M; Rangel-Zúñiga OA; Alcalá-Díaz JF; Gómez-Delgado F; Pérez-Martínez P; Delgado-Lista J; Quintana-Navarro GM; Tinahones FJ; Landa BB; López-Miranda J; Camargo A; Pérez-Jiménez F
    J Clin Endocrinol Metab; 2016 Jan; 101(1):233-42. PubMed ID: 26505825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
    Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
    Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
    Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
    Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics.
    da Silva ST; dos Santos CA; Bressan J
    Nutr Hosp; 2013; 28(4):1039-48. PubMed ID: 23889619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity.
    Van Meijel RLJ; Venema K; Canfora EE; Blaak EE; Goossens GH
    Benef Microbes; 2022 Oct; 13(4):355-364. PubMed ID: 35866596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women.
    Gomez-Arango LF; Barrett HL; Wilkinson SA; Callaway LK; McIntyre HD; Morrison M; Dekker Nitert M
    Gut Microbes; 2018; 9(3):189-201. PubMed ID: 29144833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intervention of flaxseed: effect on serum levels of IGF-1, IGF-BP3, and C-peptide.
    Sturgeon SR; Volpe SL; Puleo E; Bertone-Johnson ER; Heersink J; Sabelawski S; Wähälä K; Bigelow C; Kurzer MS
    Nutr Cancer; 2011; 63(3):376-80. PubMed ID: 21462084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.
    Dao MC; Everard A; Aron-Wisnewsky J; Sokolovska N; Prifti E; Verger EO; Kayser BD; Levenez F; Chilloux J; Hoyles L; ; Dumas ME; Rizkalla SW; Doré J; Cani PD; Clément K
    Gut; 2016 Mar; 65(3):426-36. PubMed ID: 26100928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.